PPAT and posterior cortical atrophy: Our observations lead us to hypothesise that PPAT secretome induces significant molecular alterations that could sustain the reduction in PCa cells’ sensitivity to these chemotherapeutic agents, with a greater magnitude in the case of cabazitaxel and likely independent of the expression of βIII-tubulin and P-glycoprotein.